Skip to main content
Premium Trial:

Request an Annual Quote

TessArae Gets FDA Emergency Use Authorization for H1N1 Assay

NEW YORK (GenomeWeb News) – Privately held TessArae today announced that it has received Emergency Use Authorization from the US Food and Drug Administration for its 2009 H1N1 Influenza A assay.

The firm said that the EUA for its TessArray Resequencing Influenza A Microarray Detection Panel will expire on April 26, 2010, unless terminated earlier or renewed. The targeted sequencing assay is the "first high-density, microarray-based single test intended for the in vitro qualitative detection of the 2009 H1N1 influenza A virus, aided by an algorithm that relies on seasonal A/H1N1 and seasonal A/H3N2 influenza virus results," TessArae said in a statement.

"The RM-Flu assay harnesses both DNA sequencing technologies and large public DNA sequence databases that are available today, and represents a new approach to sequencing-based diagnostics," Klaus Schäfer, president and CEO of TessArae, said in a statement.

It is the latest of several assays to receive an FDA EUA since the flu outbreak earlier this year. Among the other firms to receive EUA's for their assays are Focus Diagnostics, which is owned by clinical lab giant Quest Diagnostics, Gen-Probe's Prodesse business, clinical lab Diatherix Laboratories, Roche, and DxNA. The first assay to receive the EUA was developed by the US Centers for Disease Control and Prevention and was cleared in April.

The assay was developed through Affymetrix's MyGeneChip Custom Array Program and is authorized for use in CLIA high-complexity labs that use Affymetrix's microarray instruments.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.